CA2705902C - Procede de production de l'acide betulinique - Google Patents
Procede de production de l'acide betulinique Download PDFInfo
- Publication number
- CA2705902C CA2705902C CA2705902A CA2705902A CA2705902C CA 2705902 C CA2705902 C CA 2705902C CA 2705902 A CA2705902 A CA 2705902A CA 2705902 A CA2705902 A CA 2705902A CA 2705902 C CA2705902 C CA 2705902C
- Authority
- CA
- Canada
- Prior art keywords
- betulinic
- betulin
- aldehyde
- acid
- crude
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 title claims abstract description 87
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 title claims abstract description 78
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 title claims abstract description 78
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 title claims abstract description 78
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 title claims abstract description 78
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 238000004519 manufacturing process Methods 0.000 title abstract description 14
- FELCJAPFJOPHSD-ROUWMTJPSA-N Lup-20(29)-en-28-al, 3beta-hydroxy- Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FELCJAPFJOPHSD-ROUWMTJPSA-N 0.000 claims abstract description 59
- MHAVMNJPXLZEIG-UHFFFAOYSA-N betulinic aldehyde Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C=O)CCC(C(=C)C)C5C4CCC3C21C MHAVMNJPXLZEIG-UHFFFAOYSA-N 0.000 claims abstract description 52
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 claims abstract description 48
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 claims abstract description 48
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 claims abstract description 47
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 19
- 230000003647 oxidation Effects 0.000 claims abstract description 10
- 238000001953 recrystallisation Methods 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 57
- 239000000203 mixture Substances 0.000 claims description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 35
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 32
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 25
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 20
- 239000003960 organic solvent Substances 0.000 claims description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 230000001590 oxidative effect Effects 0.000 claims description 16
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 14
- 229910001923 silver oxide Inorganic materials 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- 239000007800 oxidant agent Substances 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims description 11
- 239000012670 alkaline solution Substances 0.000 claims description 11
- 239000012044 organic layer Substances 0.000 claims description 11
- 239000010410 layer Substances 0.000 claims description 9
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical group ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 230000020477 pH reduction Effects 0.000 claims description 5
- 239000000376 reactant Substances 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- JWUXJYZVKZKLTJ-UHFFFAOYSA-N Triacetonamine Chemical compound CC1(C)CC(=O)CC(C)(C)N1 JWUXJYZVKZKLTJ-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 10
- 239000007858 starting material Substances 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
- 239000005457 ice water Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 5
- 235000019439 ethyl acetate Nutrition 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 244000274847 Betula papyrifera Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- SLJTWDNVZKIDAU-CKURCAGRSA-N Betulonic acid Natural products CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O SLJTWDNVZKIDAU-CKURCAGRSA-N 0.000 description 1
- SLJTWDNVZKIDAU-SVAFSPIFSA-N Betulonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C SLJTWDNVZKIDAU-SVAFSPIFSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 238000006809 Jones oxidation reaction Methods 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- ZNUAKACHFYTNFX-UHFFFAOYSA-N Wallichenol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C(=C)CO)CCC3(C)CCC21C ZNUAKACHFYTNFX-UHFFFAOYSA-N 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- -1 betulinol Chemical compound 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Steroid Compounds (AREA)
Abstract
Procédé de production de l'acide bétulinique à partir de la bétuline comprenant les étapes suivantes: (1) obtention du bétulinaldéhyde brut par oxydation de la bétuline; (2) obtention de l'acide bétulinique brut par oxydation du bétulinaldéhyde brut; (3) obtention de l'acide bétulinique par recristallinisation de l'acide bétulinique brut. La présente invention permet de remédier ainsi aux défauts de l'art antérieur, en particulier dans le cas où le produit fini contient l'énantiomère de l'acide bétulinique naturel ou en cas de complexité technique. La production en est ainsi simplifiée et plus économique.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810064675.7 | 2008-06-06 | ||
CN2008100646757A CN101302244B (zh) | 2008-06-06 | 2008-06-06 | 一种桦木酸的生产方法 |
PCT/CN2009/071271 WO2009146619A1 (fr) | 2008-06-06 | 2009-04-15 | Procédé de production de l'acide bétulinique |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2705902A1 CA2705902A1 (fr) | 2009-12-10 |
CA2705902C true CA2705902C (fr) | 2013-05-14 |
Family
ID=40112358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2705902A Expired - Fee Related CA2705902C (fr) | 2008-06-06 | 2009-04-15 | Procede de production de l'acide betulinique |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101302244B (fr) |
CA (1) | CA2705902C (fr) |
WO (1) | WO2009146619A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101302244B (zh) * | 2008-06-06 | 2011-04-13 | 东北林业大学 | 一种桦木酸的生产方法 |
CN102344482A (zh) * | 2011-07-29 | 2012-02-08 | 温州大学 | 桦木醇衍生物、制备方法及用途 |
SE537100C2 (sv) * | 2011-09-12 | 2015-01-07 | Stora Enso Oyj | Förfarande för derivatisering av en kemisk komponent i trä |
SE536995C2 (sv) * | 2011-09-12 | 2014-11-25 | Stora Enso Oyj | Förfarande för derivatisering av en kemisk komponent i trä |
CN103626827A (zh) * | 2012-08-29 | 2014-03-12 | 奇复康药物研发(苏州)有限公司 | 一种白桦酸标准品制备方法 |
CN112811995A (zh) * | 2021-01-14 | 2021-05-18 | 惠泽化学科技(濮阳)有限公司 | 一种4-取代基环己酮类液晶中间体的合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804575A (en) * | 1997-03-27 | 1998-09-08 | The Board Of Trustees Of The University Of Illinois | Methods of manufacturing betulinic acid |
US6232481B1 (en) * | 2000-01-11 | 2001-05-15 | Regents Of The University Of Minnesota | Method for manufacturing betulinic acid |
CA2603124A1 (fr) * | 2005-03-29 | 2006-10-05 | Regents Of The University Of Minnesota | Oxydation selective des triterpenes a l'aide de tempo |
CN101302244B (zh) * | 2008-06-06 | 2011-04-13 | 东北林业大学 | 一种桦木酸的生产方法 |
-
2008
- 2008-06-06 CN CN2008100646757A patent/CN101302244B/zh not_active Expired - Fee Related
-
2009
- 2009-04-15 WO PCT/CN2009/071271 patent/WO2009146619A1/fr active Application Filing
- 2009-04-15 CA CA2705902A patent/CA2705902C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101302244A (zh) | 2008-11-12 |
CN101302244B (zh) | 2011-04-13 |
CA2705902A1 (fr) | 2009-12-10 |
WO2009146619A1 (fr) | 2009-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2705902C (fr) | Procede de production de l'acide betulinique | |
CN113943336B (zh) | 一种以ba为原料合成胆固醇的方法 | |
CN103724396A (zh) | 一种r-布地奈德的制备方法 | |
TWI280133B (en) | Process for preparing C-7 substituted steroids | |
WO2021005618A1 (fr) | Synthèse de cholestérol et de vitamine d3 à partir de phytostérols | |
Lian-niang et al. | Isolation and Structure Elucidation of Seco-neokadsuranic Acid A and 3, 4-Seco-(24Z)-lanosta-4 (30), 8, 24-triene-3, 26-dioic Acid1 | |
CN102558280B (zh) | 一种30-卤代桦木酸的生产方法 | |
EP3744711B1 (fr) | Procédé de préparation de mesaconine et d'intermédiaires associés | |
NO130398B (fr) | ||
CN115716862A (zh) | 新型长效芸苔素内酯、合成方法及其应用 | |
Sharma et al. | Optimization of lantadenes isolation and preparation of 22 β-hydroxyoleanonic acid | |
Pérez Gil et al. | Synthesis of analogues of brassinosteroids from chenodeoxycholic acid | |
Sakano et al. | Microbial Conversion of 18 β-Glycyrrhetinic Acid and 22 α-Hydroxy-18 β-glycyrrhetinic Acid by Chainia antibiotic | |
CN107814824B (zh) | 一种醋酸四烯物的制备方法 | |
Gómez-Calvario et al. | Synthetic pathway to 22, 23-dioxocholestanic chain derivatives and their usefulness for obtaining brassinosteroid analogues | |
Migliuolo et al. | New Δ8-and Δ8 (14)-5α-6α-epoxysterols from the marine sponge Spongia officinalis | |
Kuhl et al. | Partial synthesis of a marine secosterol from Gersemia fruticosa: Preparation of the intermediate precursor 3β, 6α-diacetoxy-24-methyl-12-oxo-5α-chol-9, 11-en-24-oate | |
RU2397177C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ 2-ДЕГИДРО-3-ЭПИ-20-ГИДРОКСИЭКДИЗОНА, МИНОРНОГО ЭКДИСТЕРОИДА СЕМЯН РАСТЕНИЙ Froelichia floridana | |
Symon et al. | Epimerization of hydroxyl group in lupan series triterpenoids | |
US3282962A (en) | (optionally 17-alkylated)-17-oxygenated-3-oxa-5alpha-androstan-2-ones and intermediates thereto | |
Liu et al. | Short and Efficient Approach Towards Buxozine‐C, an Alkaloid from Buxus sempervirens | |
He et al. | Novel Biotransformation of Digoxigenin by Colletotrichum lini AS3. 4486 | |
Nahar et al. | Synthesis of dinorcholane and 5β-cholane derivatives | |
US2854451A (en) | 11-keto-tigogenin | |
Bolt | O‐hetero‐analogues of steroids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20220419 |